Skip to main content

Featured

Markets Rebound as U.S. Ceasefire Proposal to Iran Sparks Investor Optimism

  U.S. stock futures surged early Wednesday as reports of a U.S.-backed ceasefire proposal to Iran boosted market sentiment and pushed oil prices sharply lower. Investors reacted positively to signs of potential de‑escalation in the Middle East, lifting Dow, S&P 500, and Nasdaq futures after a volatile week. U.S. stock futures climbed on Wednesday following reports that Washington sent Iran a 15‑point ceasefire plan aimed at halting the ongoing conflict in the Middle East. The development injected cautious optimism into global markets, which have been rattled by geopolitical tensions in recent weeks.  Futures tied to the Dow Jones Industrial Average and S&P 500 rose around 1% , while Nasdaq 100 futures jumped more than 1% , reversing some of the previous session’s losses. The shift in sentiment was amplified by a sharp retreat in oil prices— WTI crude fell over 5% , easing inflation concerns and improving the outlook for corporate margins.  The reported ceasef...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment